Suppose a mid-sized U.S. insurer has commissioned an independent assessment of the AI system it wants to use for claims triage. The assessor ran adversarial tests, measured error rates on historical files and reviewed the vendor’s controls. The report is favorable. It covers a defined scope, a named model version under stated conditions and does not say what the company should permit. Management must decide whether
Forbes ·